iBio
IBIO
#9815
Rank
NZ$78.43 M
Marketcap
NZ$3.49
Share price
-2.33%
Change (1 day)
-37.93%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2025 (TTM): NZ-$2.63

According to iBio's latest financial reports the company's current EPS (TTM) is NZ-$2.56. an increase over its 2024 EPS that were of NZ-$10.80.

EPS history for iBio from 2007 to 2025

Annual EPS

Year EPS Change
2025NZ-$2.91-73.08%
2024NZ-$10.80-93.88%
2023NZ-$176.38-8.14%
2022NZ-$192.0192.67%
2021NZ-$99.66-80.33%
2020NZ-$506.61-35.11%
2019NZ-$780.67-38.96%
2018NZ-$1,279-6.1%
2017NZ-$1,36236.67%
2016NZ-$996.6033.33%
2015NZ-$747.4550%
2014NZ-$498.30-53.85%
2013NZ-$1,080-7.14%
2012NZ-$1,163-64.1%
2011NZ-$3,23977.27%
2010NZ-$1,827144.44%
2009NZ-$747.4512.93%
2008NZ-$661.8812.2%
2007NZ-$589.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$17.34-777.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
NZ-$0.86-66.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ-$13.24 417.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.34-191.56%๐Ÿ‡บ๐Ÿ‡ธ USA